局部抗眼药物对梅博米腺的影响:系统性审查和元分析
Bruna Grici Cascaldi1, Antero Pinto Cardoso Filho1, Gustavo Viani Arruda2
1Department of Ophthalmology, Otorhinolaryngology and Head & Neck Surgery at Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
The ocular surface
|August 4, 2024
概括
青光眼滴可能会恶化梅博姆腺功能障碍,影响眼睛的舒适度和视力. 这次审查证实,使用这些治疗方法的患者的腺体结构和功能发生了显著的变化.
科学领域:
- 眼科医生 眼科 眼科
- 眼睛表面疾病 眼睛表面疾病
- 视光眼管理 视光眼管理
背景情况:
- 梅博米腺功能障碍 (MGD) 和玻璃眼都很常见,影响视力和生活质量.
- 局部格劳科马药物越来越多地与MGD的发展或恶化有关.
- 之前的研究表明,眼睛滴对MGD参数的影响不一致.
研究的目的:
- 系统地审查和分析青光眼药对梅博米腺形态和功能的影响.
- 为了巩固证据,关于抗葡萄糖瘤治疗和MGD之间的关系.
- 评估使用绿眼镜药物的患者的膜稳定性.
主要方法:
- 系统的文献审查.
- 临床和实验研究的元分析.
- 对梅博姆腺功能障碍的诊断参数的评估.
主要成果:
- 在使用绿眼镜眼滴的患者中,Meibomian腺形态变量的更大变化得到证实.
- 观察到梅博姆腺功能参数的显著变化.
- 有证据表明,青光眼眼滴与损害眼睛表面健康之间存在联系.
结论:
- 抗玻璃眼滴与梅博米腺结构和功能的显著改变有关.
- 这些发现突出了对管理患有眼和MGD的患者的关键考虑.
- 需要进一步的研究来探索潜在的机制和缓解策略.
相关概念视频
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Glaucoma: Overview
530
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
530
Angle Closure Glaucoma: Treatment
459
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
459
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Cholinergic Antagonists: Pharmacokinetics
425
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
425
Direct-Acting Cholinergic Agonists: Therapeutic Uses
711
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
711


